当前位置: X-MOL 学术Postgrad. Med. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Treating osteoarthritis pain: mechanisms of action of acetaminophen, nonsteroidal anti-inflammatory drugs, opioids, and nerve growth factor antibodies
Postgraduate Medicine ( IF 2.6 ) Pub Date : 2021-07-12 , DOI: 10.1080/00325481.2021.1949199
Yvonne D'Arcy 1 , Patrick Mantyh 2 , Tony Yaksh 3 , Sean Donevan 4 , Jerry Hall 5 , Mojgan Sadrarhami 4 , Lars Viktrup 6
Affiliation  

ABSTRACT

Osteoarthritis (OA) is a common difficult-to-treat condition where the goal, in the absence of disease-modifying treatments, is to alleviate symptoms such as pain and loss of function. Acetaminophen, nonsteroidal anti-inflammatory drugs (NSAIDs), and opioids are common pharmacologic treatments for OA. Antibodies directed against nerve growth factor (NGF-Abs) are a new class of agents under clinical investigation for the treatment of OA. This narrative review describes (and uses schematics to visualize) nociceptive signaling, chronification of pain, and the mechanisms of action (MOAs) of these different analgesics in the context of OA-related pain pathophysiology. Further, the varying levels of efficacy and safety of these agents observed in patients with OA is examined, based on an overview of published clinical data and/or treatment guidelines (when available), in the context of differences in their MOAs.



中文翻译:

治疗骨关节炎疼痛:对乙酰氨基酚、非甾体抗炎药、阿片类药物和神经生长因子抗体的作用机制

摘要

骨关节炎 (OA) 是一种常见的难以治疗的疾病,在没有疾病修饰治疗的情况下,其目标是减轻疼痛和功能丧失等症状。对乙酰氨基酚、非甾体抗炎药 (NSAID) 和阿片类药物是 OA 的常见药物治疗方法。针对神经生长因子 (NGF-Abs) 的抗体是一类正在临床研究中用于治疗 OA 的新型药物。这篇叙述性评论描述(并使用示意图来可视化)伤害性信号、疼痛的时间变化以及这些不同镇痛药在 OA 相关疼痛病理生理学背景下的作用机制 (MOA)。此外,检查了这些药物在 OA 患者中观察到的不同水平的有效性和安全性,

更新日期:2021-07-12
down
wechat
bug